Unlike other head and neck cancers, endemic NPC is closely associated with EBV infection, characterized by dense infiltration of lymphocytes in tumor stroma and positive PD-L1 expression in tumor cells, making it an attractive target for immunotherapy, especially immune checkpoint inhibitors (17). The gene discussed is CD274; the disease is nasopharyngeal carcinoma.